A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.

A surgical treatment apparatus comprises a waterjet configured to fragment tissue and provide intact cells such as stem cells with the fragmented tissue. The intact cells can be used in one or more of many ways such as for genetic or other testing, and the intact cells can be identified as stem cells. In many embodiments, the intact cells comprise stem cells. In many embodiments, a waterjet is configured to fragment tissue. The fragmented tissue can be collected with a filter having pores sized smaller than the tissue fragments. In many embodiments cavitation with a waterjet is used to fragment the tissue comprising the intact stem cells. The waterjet may comprise a waterjet immersed in a liquid comprising water so as to form a plurality of shedding pulses. The plurality of shedding pulses can be generated with a frequency sufficient to fragment the tissue. The shedding pulses can generate cavitations that fragment the tissue.

A fluid ejection device includes a fluid chamber, a volume varying unit, a fluid supplying unit, and an ejection pipe. The volume varying unit generates pulsation in the pressure of a fluid in the fluid chamber. The fluid supplying unit supplies the fluid to the fluid chamber through a first channel. The ejection pipe receives the supply of the fluid, in which the pulsation is generated, from the fluid chamber through a second channel and ejects the supplied fluid from an ejection port. In a connecting part to the fluid chamber, the cross-sectional area of the second channel is five times or more as large as the cross-sectional area of the first channel. In the connecting part to the fluid chamber, the first channel and the second channel are arranged to be opposed to each other via the vicinity of the center of the fluid chamber.

A liquid ejection device includes an ejection tube, a gripping tube, a liquid chamber, a connection channel, and a pulsed-flow generating section. The ejection tube is a tube for ejecting liquid. The gripping section is an instrument attached to the ejection tube and gripped by a user. The liquid chamber is provided on the outside of the gripping section. The connection channel connects the liquid chamber and the ejection tube. The pulsed-flow generating section is provided on the outside of the gripping section and generates a pulsed flow in the liquid in the liquid chamber.

A liquid injection device that injects a liquid includes a liquid chamber, a first channel connected to the liquid chamber and feeding a liquid to the liquid chamber, a second channel connected to the liquid chamber, to which the liquid is fed from the liquid chamber, and an injection tube that communicates with the second channel and injects the liquid, and the second channel has a curved shape.

Liquid is ejected in a pulse-like manner from a nozzle provided at the distal end of a liquid ejection pipe. When the liquid is ejected, moving speed of the nozzle is detected. A driving frequency of a piezoelectric element is increased when the moving speed increase. The driving frequency is reduced when the moving speed decreases. Consequently, it is possible to prevent the number of times the liquid is ejected per unit length from changing according to the moving speed of the nozzle. Therefore, it is possible to excise a biological tissue at stable excision depth.

A liquid ejecting device includes a driving waveform signal generating circuit that generates a driving waveform signal, a modulation circuit that performs pulse modulation on the driving waveform signal to generate a modulation signal, a digital power amplifier that amplifies power of the modulation signal to generate a power amplification modulation signal in the form of a pulse wave, a filter that smoothes the power amplification modulation signal in the pulse wave to generate the driving signal, a connection cable that connects the filter to the capacitive load and is provided such that at least one of the filter and the capacitive load is detachable, a connection line information acquiring unit that acquires connection line information associated with the connection cable, and a frequency changing unit that changes a frequency when the modulation circuit performs the pulse modulation on the driving waveform signal, on the basis of the connection line.

A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.

A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.

A surgical treatment apparatus comprises a waterjet configured to fragment tissue and provide intact cells such as stem cells with the fragmented tissue. The intact cells can be used in one or more of many ways such as for genetic or other testing, and the intact cells can be identified as stem cells. In many embodiments, the intact cells comprise stem cells. In many embodiments, a waterjet is configured to fragment tissue. The fragmented tissue can be collected with a filter having pores sized smaller than the tissue fragments. In many embodiments cavitation with a waterjet is used to fragment the tissue comprising the intact stem cells. The waterjet may comprise a waterjet immersed in a liquid comprising water so as to form a plurality of shedding pulses. The plurality of shedding pulses can be generated with a frequency sufficient to fragment the tissue. The shedding pulses can generate cavitations that fragment the tissue.